"Monsanto’s (MON +2.8%) doing a lot of things right," OptionMonster’s Jon Najarian tells CNBC, adding the stock's two-year rise could continue as demand grows for MON’s genetically engineered, drought-resistant seeds. Shares are strong today, as investors focus on Goldman's upgrade rather than a study that said rats developed tumors after being exposed to certain MON products.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.